These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6369209

  • 1. [A new principle in endocrine therapy of metastatic breast cancer: aminoglutethimide, an antiestrogen with aromatase-inhibiting action].
    Drees N.
    Onkologie; 1984 Feb; 7(1):52-6. PubMed ID: 6369209
    [No Abstract] [Full Text] [Related]

  • 2. Aminoglutethimide as an aromatase inhibitor in the treatment of cancer.
    Santen RJ.
    Cancer Treat Rev; 1984 Dec; 11(4):325-9. PubMed ID: 6534513
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose aminoglutethimide and aromatase inhibition.
    Dowsett M, Jeffcoate SL, Santner S, Santen RJ, Stuart-Harris R, Smith IE.
    Lancet; 1985 Jan 19; 1(8421):175-6. PubMed ID: 2857259
    [No Abstract] [Full Text] [Related]

  • 4. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
    Dowsett M, Santner SJ, Santen RJ, Jeffcoate SL, Smith IE.
    Br J Cancer; 1985 Jul 19; 52(1):31-5. PubMed ID: 4015950
    [Abstract] [Full Text] [Related]

  • 5. Closing remarks to the conference, Aromatase: New Perspectives for Breast Cancer.
    Lipton A, Harvey HA, Santen RJ.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3468s. PubMed ID: 7083210
    [No Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ, Santner SJ, Tilsen-Mallett N, Rosen HR, Samojlik E, Veldhuis JD.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aminoglutethimide enzyme induction: pharmacological and endocrinological implications.
    Lønning PE.
    Cancer Chemother Pharmacol; 1990 Aug 19; 26(4):241-4. PubMed ID: 2369789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of aromatase inhibitors in breast cancer.
    Powles TJ.
    Semin Oncol; 1983 Dec 19; 10(4 Suppl 4):20-4. PubMed ID: 6367051
    [Abstract] [Full Text] [Related]

  • 14. [Aminoglutethimide - a new drug for the after care in breast cancer].
    Rabe T, Rabe D, Runnebaum B.
    Fortschr Med; 1981 Nov 19; 99(43):1816-8. PubMed ID: 7308944
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. First generation aromatase inhibitors--aminoglutethimide and testololactone.
    Cocconi G.
    Breast Cancer Res Treat; 1994 Nov 19; 30(1):57-80. PubMed ID: 7949205
    [Abstract] [Full Text] [Related]

  • 20. Basic studies on aminoglutethimide.
    Salhanick HA.
    Cancer Res; 1982 Aug 19; 42(8 Suppl):3315s-3321s. PubMed ID: 7083193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.